On September 9, INNOSCIENCE rose 5.6% in regular trading, trading at HK$45.72/share, with turnover of HK$97.02 million. The rally was driven by a cluster of bullish analyst endorsements and strong fundamental momentum.

On the news front, CLSA maintained its Outperform rating on the company with a target price of HK$112. Earlier, CMB International set a target price of HK$74.2, citing improving product mix and margin expansion, while Daiwa initiated coverage with a Buy rating, projecting that 800V AI data center buildouts could generate US$540 million to US$4.5 billion in GaN power device demand between 2027 and 2030. As the worlds largest GaN power device supplier with approximately 30% market share, INNOSCIENCE is positioned as a key beneficiary.

Fundamentally, the company reported H1 revenue of RMB 834 million, up 50.6% year-over-year, with gross margin rising to 11.6% from 6.8%. Operating net cash flow turned positive for the first time at approximately RMB 169 million, compared with a net outflow of RMB 387 million a year earlier. Revenue from high-end applications surged 70% year-over-year to RMB 532 million, outpacing consumer segment growth.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)